Generics & Biosimilars Manufacturers

When you're managing hundreds of SKUs across multiple markets, efficiency is everything. Our platform turns regulatory complexity into a strategic advantage with automated intelligence.

futuristic classroom settingdigital project interface filling the entire background

Automate

reference listed drug (RLD) monitoring to de-risk your strategy to avoid regulatory enforcement actions.

De-risk

your strategy with contemporary and accurate evidence–driven insights from across the market landscape.

Accelerate

strategic decision-making and time-to-market with specialized workflows and fit-for-purpose AI.

Automate

time-intensive, routine tasks so you operate strategically at the top of your capabilities.

Expand

shared insights across the enterprise, break down silos, and increase collaboration with a single solution.

“The process of automated label monitoring eliminates 40-60% of the effort compared to doing it manually. This allows us to be more strategic, support other teams, and expand into new geographies.”

Associate Director of Labeling, Top-tier generics company.  

“With automation, safety updates are on time. It lets managers to more quickly manage safety updates and optimizes the pharmacovigilance team’s focus.

Associate Director of Labeling, Top-tier generics company.

We Help You

Optimize

Optimize your label from day one by understanding what regulators have accepted for similar molecules.

Accelerate

Compress timelines from first-in-human to approval with rapid insights into precedent-proven regulatory pathways in your therapeutic area.

Compete

Compete at peak performance with enterprise-grade labeling and regulatory intelligence at a fraction of the cost of building in-house capabilities.

Accelerate decisions. Optimize outcomes.

Join the leading biopharma companies worldwide who've made Dr.Evidence their competitive advantage. Get the landscape intelligence platform that grows with you—from first submission to long-term commercial success.

Book a Demo